StartUps
– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)...
Hi, what are you looking for?
– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)...
– Berg has devoted considerable time, energy as well as capital in his latest venture, Berg Pharma in the search for new treatments for...
– The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. –...
– Brainsway has leased a Deep TMS system to Harvard University’s McLean Hospital. – – Brainsway Ltd. (TASE:BRIN) has leased a Deep TMS (transcranial magnetic...
– – The average person has two broken bones in their lifetime, which can be caused by everything from arthritis, osteoporosis, accidents and side...
– GlaxoSmithKline and BioRap will commercialize a treatment for lethal side effects of bone marrow transplants. – – Pharmaceutical giant GlaxoSmithKline plc (LSE: GSK)...
– – San Diego, California based Illumina Inc, listed on NASDAQ ILMN , makes gene sequencing machines and other tools for the bio technology industry. Since...
– CathMaps+, Which Was Launched Today in the U.S., Combines HIPAA Compliant Storage of Cardiac Medical Records With Interactive Map of Catheterization Labs Worldwide....
PLX-PAD cells show statistically significant improvement over placebo in the change of the maximal contraction force of the gluteal muscle .
– Press Release BiondVax’s universal flu vaccine matches all 6 potentially pandemic flu strains in the world today: H5N1, H5N8, H6N1, H7N7, H7N9...